ATMP logo

ATMP ETF

Profile

Name:

Barclays ETN+ Select MLP ETN

Assets under management:

$422 M

Expense ratio:

0.95%

Inception date:

13 March 2013

Website:

-

Last ex-dividend date:

15 November 2024

Next ex-dividend date:

N/A

Description:

The ATMP ETF is an exchange-traded fund that focuses on companies involved in advanced therapies, including gene therapy, cell therapy, and tissue engineering. It offers investors exposure to innovative healthcare solutions aimed at treating various diseases and improving patient outcomes.

Top holdings

No data

Holding types

Countries

No data

Sectors

No data

Analyst ratings

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

FAQ

  • What is ATMP ETF?
  • Does ATMP pay dividends?
  • What is the current assets under management for ATMP?
  • What is ATMP average volume?
  • What is ATMP expense ratio?
  • What is ATMP inception date?

What is ATMP ETF?

The ATMP ETF is an exchange-traded fund that focuses on companies involved in advanced therapies, including gene therapy, cell therapy, and tissue engineering. It offers investors exposure to innovative healthcare solutions aimed at treating various diseases and improving patient outcomes.

Does ATMP pay dividends?

Yes, the Barclays ETN+ Select MLP ETN does pays dividends, with the most recent payment being $0.35 per share. The last ex-dividend date was on 15 November 2024, and the next ex-dividend date has not been announced yet

What is the current assets under management for ATMP?

Assets under management of Barclays ETN+ Select MLP ETN is $422 M

What is ATMP average volume?

Average volume of Barclays ETN+ Select MLP ETN is $50 K

What is ATMP expense ratio?

Expense ratio of Barclays ETN+ Select MLP ETN is 0.95%

What is ATMP inception date?

Inception date of Barclays ETN+ Select MLP ETN is 13 March 2013